Multiple Assemblies exist for SMTL entry 6b73
Crystal Structure of a nanobody-stabilized active state of the kappa-opioid receptor; X-RAY DIFFRACTION 3.10 Å

	SMTL ID 6b73.1 Ligands N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide; CHOLESTEROL; OLEIC ACID Polypeptides Soluble cytochrome b562, kappa-type opioid receptor; Nanobody Oligo-state hetero-1-1-mer
	SMTL ID 6b73.2 Ligands N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide; CHOLESTEROL Polypeptides Soluble cytochrome b562, kappa-type opioid receptor; Nanobody Oligo-state hetero-1-1-mer